Published on 14 Dec 2021 on Simply Wall St. via Yahoo Finance
If you want to know who really controls Cara Therapeutics, Inc. (NASDAQ:CARA), then you'll have to look at the makeup of its share registry. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. Companies that have been privatized tend to have low insider ownership.
Cara Therapeutics is not a large company by global standards. It has a market capitalization of US$651m, which means it wouldn't have the attention of many institutional investors. Our analysis of the ownership of the company, below, shows that institutional investors have bought into the company. We can zoom in on the different ownership groups, to learn more about Cara Therapeutics.
See our latest analysis for Cara Therapeutics